MANOGNA PUCHHALAPALLI: Open Payments
NPI 1144904285 · HIRAM, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,844 in 84 payments from 31 companies in 2025. Trend: 2023 $252 · 2024 $495 · 2025 $1,844
Food & beverage: $1,688Education: $155
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $174 |
| Merck Sharp & Dohme LLC | 6 | $167 |
| Incyte Corporation | 4 | $139 |
| Janssen Biotech, Inc. | 7 | $138 |
| AstraZeneca Pharmaceuticals LP | 5 | $121 |
| Daiichi Sankyo Inc. | 5 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $93 |
| Genentech USA, Inc. | 4 | $93 |
| Stemline Therapeutics Inc. | 3 | $79 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
Products named: KEYTRUDA, Enhertu, Orserdu, DARZALEX, BRAFTOVI, TUKYSA, OPDUALAG, ZEPZELCA.
Industry payments across GA — which companies pay providers there.
